Lung disease Clinical Trials in Los Angeles, CA
As of August 2026, 36 paid clinical trials are recruiting for Lung disease in Los Angeles, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Los Angeles
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
37 clinical trials for Lung disease
·Clear filters·Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
EXoPERT EMERALD Clinical Study
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Maralixibat in Patients With Cystic Fibrosis and Constipation
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Top Research Study Locations in Los Angeles
Researchers run research studies in Los Angeles, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cedars-Sinai Medical Center | Heart Failure, Acute Myeloid Leukemia, Breast Cancer | 228 |
| Children's Hospital Los Angeles | Neuroblastoma, Acute Myeloid Leukemia, Anesthesia | 129 |
| University of California, Los Angeles | Amyotrophic Lateral Sclerosis, Depression, Focal Epilepsy | 109 |
| University of Southern California | Acute Pancreatitis, Breast Cancer, Cervical Cancer | 96 |
| USC / Norris Comprehensive Cancer Center | Breast Carcinoma, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | 66 |
| UCLA / Jonsson Comprehensive Cancer Center | Prostate Carcinoma, Glioblastoma, Anatomic Stage II Breast Cancer AJCC v8 | 65 |
| University of California Los Angeles | Parkinson Disease, Bladder Cancer, Breast Cancer | 65 |
| Cedars Sinai Medical Center | Anxiety, Crohn's Disease, Heart Failure | 63 |
| UCLA | Bladder Cancer, Colorectal Cancer, Acute Lymphoblastic Leukemia (ALL) | 56 |
| Los Angeles General Medical Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 52 |
| USC Norris Comprehensive Cancer Center | Advanced Solid Tumors, Colorectal Cancer, Endometrial Cancer | 50 |
| Kaiser Permanente Los Angeles Medical Center | Intracerebral Hemorrhage, Ischemic Stroke, Stage IV Lung Cancer AJCC v8 | 42 |
| Children's Hospital of Los Angeles | Acute Lymphoblastic Leukemia, Cystic Fibrosis, Von Willebrand Disease (VWD) | 35 |
| Valkyrie Clinical Trials | Multiple Myeloma, Non-Small Cell Lung Cancer, Breast Cancer | 33 |
| Ronald Reagan UCLA Medical Center | Ischemic Stroke, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma | 25 |
| UCLA Medical Center | Colorectal Cancer, CRC, Cancer | 22 |
| USC/Norris Comprehensive Cancer Center | Breast Neoplasms, Bladder Cancer, Breast Cancer | 22 |
| Kaiser Permanente West Los Angeles | Breast Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 16 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Non-alcoholic Fatty Liver Disease, Breast Neoplasms | 15 |
| START Los Angeles | Advanced Solid Tumors, Colorectal Cancer, Endometrial Cancer | 14 |
| Cedars Sinai | 1st Line NSCLC, Advanced Solid Tumor, Aortic Valve Disease Mixed | 13 |
| David Geffen School of Medicine at UCLA | Candidemia, Candidiasis, Invasive, Developmental and Epileptic Encephalopathy | 13 |
| Keck Hospital of USC | Advanced Hepatocellular Carcinoma, Advanced or Metastatic Solid Tumors, Airway Disease | 13 |
| Keck Medicine of USC Koreatown | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 13 |
| Mattel Children's Hospital UCLA | Malignant Solid Neoplasm, Ganglioneuroblastoma, Nodular, Hematopoietic and Lymphatic System Neoplasm | 12 |
Active & Upcoming Studies in Los Angeles (2026)
Recruiting trials in Los Angeles grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (636 active studies)
- Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · Jonsson Comprehensive Cancer Center
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (111 active studies)
- The Role of Virtual Reality During Regional Anesthesia · Cedars-Sinai Medical Center
- IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success · Lucas R. Cusumano, MD
Cardiovascular (97 active studies)
Mental health & behavior (62 active studies)
- A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs · NYU Langone Health
- Group PACBT for Depression · Phase 2 · University of California, Los Angeles
Diabetes & metabolic (61 active studies)
- Screening For Social Determinants Of Health In Routine Diabetes Care · University of California, Los Angeles
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Pediatric (33 active studies)
- Asthma Lung Sounds With Wearable Stethoscope · Children's Hospital Los Angeles
- Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · Phase 2 · BrainChild Bio, Inc
HIV / STI (23 active studies)
- Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization · Keck School of Medicine of USC
- A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs · NYU Langone Health
Eye & vision (13 active studies)
- Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension · Stanford University
- Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery · University of California, Los Angeles
Vaccines (9 active studies)
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age · Phase 3 · GlaxoSmithKline
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi
Common conditions studied in Los Angeles
- Breast Cancer (38 active studies)
- Colorectal Cancer (31 active studies)
- Prostate Cancer (27 active studies)
- Ovarian Cancer (23 active studies)
- Cancer (22 active studies)
- Heart Failure (21 active studies)
Leading research sponsors in Los Angeles
- University of California, Los Angeles
- University of Southern California
- Cedars-Sinai Medical Center
- Jonsson Comprehensive Cancer Center
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Los Angeles?
There are approximately 1,970 recruiting clinical trials in Los Angeles, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Los Angeles pay participants?
Most recruiting trials in Los Angeles compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Los Angeles?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Los Angeles?
The most common conditions under active study in Los Angeles include Breast Cancer (38), Colorectal Cancer (31), Prostate Cancer (27), Ovarian Cancer (23), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Los Angeles?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Los Angeles on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Los Angeles?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Los Angeles?
Recruiting research sites in Los Angeles include Cedars-Sinai Medical Center, Children's Hospital Los Angeles, University of California, Los Angeles, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Los Angeles right now?
The largest active categories in Los Angeles are Cancer & tumors (636), Neurology & pain (111), Cardiovascular (97). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.